AGBL3 and rheumatoid arthritis: In aggregate, these findings of DNA methylation patterns demonstrate that there is ‘general’ immune dysregulation in At-Risk compared to anti-CCP3(−) Controls, but more defined abnormalities between Early RA and At-Risk that may might identify pathways that are key to a transition to RA, and potentially be targets for prevention or early treatment.